Chromatin modification and three-dimensional (3D) chromosome structure play central roles in regulating gene expression ([@R48]; [@R10]; [@R42]; [@R35]; [@R41]). However, the role of histone modifications in establishing higher-order chromosome structure during gene regulation has been elusive.

Histone modifications are known to alter the interactions between nucleosomes that govern the compaction state of a chromatin fiber ([@R12]; [@R28]; [@R19]). However, the effect of histone modifications on higher-order chromosome organization beyond chromatin-fiber compaction is not well understood. Only recently has super-resolution imaging shown that chromatin domains enriched in H3K27me3 and Poly-comb proteins adopt unique folded states ([@R3]). Once the Polycomb repressive complex 1 is recruited to H3K27me3-enriched chromatin, it generates chromatin domains 20--140 kb in size ([@R24]). These domains are distinct from topologically associating domains (TADs), which are self-interacting genomic regions up to 1 Mb in size that permit loci within a domain to interact with each other but insulate these loci from interactions with loci in other TADs ([@R34]).

We analyzed X-chromosome dosage compensation in the nematode *Caenorhabditis elegans* to explore the relationship between chromatin modification and higher-order chromosome structure during chromosome-wide gene regulation. Dosage compensation is achieved by a 10-subunit dosage compensation complex (DCC) that binds to both hermaphrodite X chromosomes via sequence-dependent recruitment elements on X (*rex* sites) to reduce transcription by half ([Fig. 1A,C](#F1){ref-type="fig"}; [@R7]; [@R17]; [@R30]; [@R31]). This chromosome-wide modulation of gene expression ensures that males (XO) and hermaphrodites (XX) express equivalent levels of X-chromosome products despite their unequal dose of X chromosomes. Five DCC subunits ([Fig. 1B](#F1){ref-type="fig"}) are homologous to subunits of condensin, a complex conserved from yeast to man that compacts and resolves chromosomes in preparation for chromosome segregation during mitosis and meiosis ([@R7]; [@R30]; [@R31]; [@R14]). The similarity between the DCC and condensin suggested that the DCC might remodel the structure of X to achieve gene repression.

Indeed, the DCC imposes a distinct higher-order structure onto both hermaphrodite X chromosomes while repressing gene expression. It remodels the topology of X into a sex-specific spatial conformation distinct from that of autosomes or male X chromosomes by forming TADs of \~1 Mb ([@R6]). The highest-affinity *rex* sites are located at TAD boundaries and several observations support a model in which DCC-dependent looping interactions between these high-affinity *rex* sites direct TAD formation ([@R6]). (1) Interactions between *rex* sites are among the most prominent long-range interactions along the X chromosome, and disruption of the DCC abolishes the interactions and TAD structure. (2) The stronger the *rex* sites, the more frequent are the DCC-dependent interactions among them. (3) Deletion of a single high-affinity *rex* site at a TAD boundary eliminates formation of the TAD boundary. Thus, not only does a condensin complex play a key role in compacting and resolving mitotic and meiotic chromosomes, it plays a central role in shaping the 3D landscape of interphase chromosomes.

During this chromosome remodeling process, the chromatin modification H4K20me1 becomes selectively enriched on both hermaphrodite X chromosomes in a DCC-dependent manner ([Fig. 2A](#F2){ref-type="fig"}; [@R26]; [@R47]; [@R50]; [@R23]). H4K20me1 is also selectively enriched on the inactive X chromosome of female mammals, highlighting a shared feature of diverse dosage compensation strategies ([Fig. 2A](#F2){ref-type="fig"}; [@R21]). In neither case had the mechanism of H4K20me1 enrichment been discovered. Furthermore, the effect of the H4K20me1 modification on gene regulation and chromosome structure had not been determined.

In general, the role of H4K20me1 in gene regulation has remained a mystery because of its contribution to both gene activation and gene repression in different contexts ([@R1]). Although H4K20 methylation has been implicated in many nuclear functions beyond gene regulation, such as DNA replication and repair, mitotic chromosome condensation, and cell cycle control, the mechanisms that regulate different H4K20 methylation states and transduce them into correctly executed nuclear functions are not understood ([Fig. 2B](#F2){ref-type="fig"}; [@R1]; [@R18]; [@R46]). We discovered the machinery and mechanism that catalyze H4K20me1 enrichment on nematode X chromosomes and the impact of H4K20me1 on higher-order chromosome structure and gene regulation ([@R4]).

In principle, H4K20me1 enrichment on nematode X chromosomes could occur by activating the methyltransferase that converts H4K20 to H4K20me1 (SET-1), by blocking the methyltransferase that converts H4K20me1 to H4K20me2/me3 (SET-4), by blocking the demethylase that converts H4K20me1 to H4K20 (JMJD-1.1/1.2), or by activating an unknown demethylase that converts H4K20me2 to H4K20me1 ([Fig. 2B](#F2){ref-type="fig"}). Although H4K20me2 is the most abundant form of H4K20 in eukaryotic cells ([@R37]), only a neuron-specific H4K20me2 demethylase had been reported ([@R49]). No H4K20me2 demethylase had been identified that could function during the dosage compensation process. Indeed, published models featured the inhibition of SET-4 as the likely mechanism for H4K20me1 enrichment on X in *C. elegans* ([@R47]; [@R50]; [@R23]). In contrast, our X-ray crystallography and biochemical assays of the DCC subunit DPY-21 revealed a new subfamily of Jumonji C (JmjC) histone demethylases that converts H4K20me2 to H4K20me1 in vitro and is widely conserved from worms to mammals ([@R4]). We showed that DPY-21 catalyzes H4K20me1 enrichment on X in vivo, and H4K20me1 enrichment, in turn, helps remodel the higher order of structure of X chromosomes ([@R4]).

DCC SUBUNIT DPY-21 AND MOUSE ROSBIN PROTEIN ARE THE FIRST JUMONJI C (JmjC) DEMETHYLASES THAT CONVERT H4K20me2 TO H4K20me1 {#S1}
=========================================================================================================================

Although amino acid sequence analysis failed to identify a demethylase domain in any of the 10 DCC subunits, structure prediction programs suggested homology between the carboxy-terminal domain of DPY-21 and JmjC domain--containing lysine demethylases (KDMs), despite low (15%) sequence identity. JmjC KDMs are Fe^2+^ and α-ketoglutarate (α-KG)-dependent dioxygenases that demethylate lysines in histone and nonhistone proteins ([@R29]). This potential connection was investigated by determining a 1.8 Å crystal structure of the *C. elegans* DPY-21^1210--1617^ fragment that encompasses the putative JmjC domain ([@R4]). Comparisons to known structures ([@R15]) revealed DPY-21 to be a JmjC domain--containing protein most similar to the JmjC KDMs ([Fig. 3A,B](#F3){ref-type="fig"}).

Like other JmjC KDMs, the DPY-21^1210--1617^ structure includes a JmjC domain that is folded into a double-stranded β-helix (DSBH) and surrounded by a Jumonji N (JmjN) domain, a β-hairpin motif, and a mixed domain ([Fig. 3A](#F3){ref-type="fig"}; [@R5]). The DPY-21 DSBH core bears facial triad residues (H1452, D1454, and H1593) that chelate Fe^2+^ and form an active site ([Fig. 3B](#F3){ref-type="fig"}). An α-KG molecule coordinates Fe^2+^ in a bidentate manner, and a water molecule completes the octahedral coordination of Fe^2+^ ([Fig. 3B](#F3){ref-type="fig"}). The α-KG is further stabilized by hydrogen bonding to side chains of T1449 and Y1585 and also by hydrogen bonding to side chains of W1410, K1526, and S1603 via water molecules. In addition, α-KG forms van der Waals contacts with A1499, L1587, and F1595.

The DPY-21 carboxy-terminal domain is similar (33% identity) to carboxy-terminal domains of metazoan proteins named round spermatid basic proteins 1 (ROSBIN) ([Fig. 3C](#F3){ref-type="fig"}; [@R51]). Mouse ROSBIN, an essential protein with limited biochemical characterization, is expressed in embryos and male gonads ([@R44]; [@R22]). Structure-guided sequence comparison of ROSBIN proteins with DPY-21 showed that all residues that interact with Fe^2+^ and α-KG are conserved. Moreover, sequence conservation ex tends to regions participating in histone peptide binding, as defined by JmjC KDM structures ([@R29]), suggesting that ROSBINs may also be JmjC de-methylases that share substrate specificity.

Assays performed in vitro with modified histones showed that both DPY-21 and mROSBIN convert H4K20me2 to H4K20me1, demonstrating the evolutionary conservation of a novel H4K20me2 JmjC demethyase activity ([@R4]). mRosbin also demethylated an H4K20me2 peptide in vitro ([@R4]). Substitution of facial triad residues (H1452A and D1454A) in DPY-21 abolished enzymatic activity, and both proteins were inactive without their Fe^2+^ and α-KG cofactors ([@R4]). Furthermore, both DPY-21 and mROS-BIN have a strong preference for H4K20me2 as a substrate, because neither protein was active in vitro with H4K20me1, H4K20me3, or histone H3 methyl substrates ([@R4]).

The single previously identified H4K20me2 demethylase (nLSD1) is a neuronal-specific isoform of LSD1 that uses different chemistry from JmjC domains ([@R49]). nLSD1 is a flavin-dependent monoamine oxidase that demethylates both H4K20me2 and H4K20me1. The only JmjC H4K20 demethylases identified before DPY-21 and ROSBIN have specificity for H4K20me3 (PHF2) and H4K20me1 (PHF8) ([@R27]; [@R39]; [@R43]). Both have an amino-terminal PHD domain required for demethylase activity in vitro, which occurs only in the context of nucleosomes. In contrast, DPY-21 and mROSBIN lack PHD and other chromatin-interacting domains and only require the JmjC domain for substrate recognition, allowing them to demethylate H4K20me2 in vitro on histone and histone peptides. These structural and biochemical findings merit classifying DPY-21 and ROSBIN proteins as a new subfamily of JmjC demethylases, the KDM9 subfamily.

THE DPY-21 JmjC DEMETHYLASE ACTS IN A CELL-CYCLE-DEPENDENT MANNER TO ENRICH H4K20me1 ON X CHROMOSOMES OF SOMATIC CELLS {#S2}
======================================================================================================================

H4K20me1 enrichment on hermaphrodite X chromosomes occurs in a cell cycle--dependent manner, during interphase but not mitosis, where H4K20me1 levels are uniformly elevated on all chromosomes ([Fig. 4A,B](#F4){ref-type="fig"}; [@R4]). H4K20me1 enrichment is not evident on interphase X chromosomes before the 200-cell stage of embryogenesis and only becomes reliably detectable on X in most interphase cells around the 300--350-cell stage, long after initial recruitment of SDC-2 and other DCC subunits to X (30--40-cell stage) ([Fig. 4A](#F4){ref-type="fig"}; [@R4]). In contrast to other DCC subunits, DPY-21's association with X is precisely coincident with the timing of H4K20me1 enrichment on X. Moreover, DPY-21 is not bound to mitotic chromosomes, unlike other DCC subunits ([Fig. 4B](#F4){ref-type="fig"}). These results suggest that DPY-21 de-methylates H4K20me2 on X to enrich H4K20me1.

In three different genome-engineered strains expressing DPY-21 variants with substitutions in JmjC facial triad amino acids (H1452A, D1454A, or H1452A/D1454A), sex-specific enrichment of H4K20me1 was absent from interphase X chromosomes ([Fig. 4A](#F4){ref-type="fig"}). In contrast, HK20me1 levels were unaffected on mitotic chromosomes ([Fig. 4A,B](#F4){ref-type="fig"}; [@R4]).

In chromatin immunoprecipitation sequencing (ChIP-seq) experiments measuring the genome-wide distribution of H4K20me1 in wild-type and *dpy-21(JmjC)*-mutant embryos using a spike-in control to normalize read count, H4K20me1 was enriched on X compared to autosomes in wild-type but not in demethylase-mutant embryos ([Fig. 4C](#F4){ref-type="fig"}; [@R4]). Loss of H4K20me1 enrichment on X in *dpy-21(JmjC)* mutants coupled with the timing of DPY-21's association with X during interphase and DPY-21's absence from mitotic chromosomes indicate that JmjC demethylase activity is responsible for X enrichment of H4K20me1.

LOSS OF H4K20me2 DEMETHYLASE ACTIVITY DISRUPTS DOSAGE COMPENSATION AND ELEVATES X-LINKED GENE EXPRESSION {#S3}
========================================================================================================

Prior studies aimed at understanding the role of H4K20me1 enrichment on X during dosage compensation used RNAi-mediated knockdown of the methyltransferase gene *set-1* to reduce H4K20me1 levels genome-wide or mutation of *set-4* to block the progression of H4K20me1 to H4K20me2/me3, thereby increasing H4K20me1 levels across all chromosomes ([@R47]; [@R50]; [@R23]). The resulting genome-wide changes in gene expression made it difficult to assess the specific importance of H4K20me1 levels on X during dosage compensation. Furthermore, interpretation of genetic assays evaluating dosage compensation defects ([@R47]; [@R50]) was confounded, in retrospect, by the finding that *set-1* knockdown causes synergistic lethality in both sexes from defective mitosis ([@R4]).

In contrast, the highly specific *dpy-21(JmjC)* mutations enabled us to eliminate H4K20me1 enrichment selectively from X and show through genetic assays and direct RNA measurements that loss of demethylase activity disrupts dosage compensation. The role of H4K20me1 was assessed by first asking whether *dpy-21(JmjC)* mutations suppress the XO-specific lethality caused by *xol-1* mutations, which inappropriately activate the DCC in males. *xol-1*, the master regulator of sex-determination and dosage compensation, acts in XO embryos to turn off the hermaphrodite pathway of sexual differentiation and to prevent DCC binding to the single male X by repressing *sdc-2*, the XX-specific trigger of DCC binding to X ([@R32]; [@R40]; [@R9]). *xol-1* mutant XO animals die from reduced X-linked gene expression. If the JmjC catalytic activity is important for reducing X expression during dosage compensation, mutations that inactivate this demethylase should suppress the *xol-1* XO-specific lethality. Indeed, JmjC mutations prevented the death of *xol-1* XO males, indicating that *dpy-21(JmjC)* mutations disrupt dosage compensation, and H4K20me1 enrichment is important for the dosage compensation mechanism ([@R4]).

The importance of demethylase activity in repressing gene expression predicts that blocking H4K20me2/me3 production via a *set-4* mutation should prevent the rescue of *xol-1* XO males by *dpy-21(JmjC)* mutations. This prediction held true, providing strong genetic evidence that production of H4K20me2/me3 on X is an intermediate step in the enrichment of H4K20me1 on X ([@R4]).

The effect of *dpy-21(JmjC)* mutations on X-chromosome gene expression was shown directly by RNA-seq experiments. Cumulative plots comparing the distribution of fold changes in gene expression on X chromosomes and autosomes between wild-type and *dpy-21* mutant embryos revealed that X-chromosome gene expression was significantly elevated relative to that of each individual autosome in *dpy-21(JmjC)* mutants ([Fig. 5](#F5){ref-type="fig"}). Similar results were obtained for *dpy-21(null)* mutants, but the relative elevation in X expression was somewhat greater ([Fig. 5](#F5){ref-type="fig"}), consistent with the more severe mutant phenotypes for null mutants ([@R4]). These findings show that DPY-21's demethylase activity, and by extension the enrichment of H4K20me1 on X, functions in vivo to help repress X-chromosome gene expression.

Chromatin with posttranslationally modified histones can recruit specialized proteins ("readers") to control the structure of nucleosome arrays and regulate gene expression ([@R42]). In particular, chromatin readers of the malignant brain tumor (MBT) repeat protein family associate with nucleosomes enriched in H4K20me1 or H4K20me2, help compact the chromatin fiber, and repress gene expression ([@R45]; [@R2]). However, knockout of the two *C. elegans* MBT repeat proteins, *mbtr-1* and *lin-61*, failed to suppress *xol-1* XO lethality, unlike *dpy-21(JmjC)* mutations, indicating a lack of dosage compensation defects ([@R4]). This result implies that if H4K20me1-binding proteins modulate X-chromosome conformation and gene repression, they must belong to an unidentified family of H4K20me1 readers. As alternatives, H4K20me1 might antagonize other proteins with chromatin-modifying activities, or less likely, it might control chromatin folding directly.

H4K20me1-DRIVEN REMODELING OF X-CHROMOSOME TOPOLOGY {#S4}
===================================================

X chromosomes undergo changes in conformation during dosage compensation. Cytological studies measuring the volumes of chromosome territories showed that DCC binding increases the compaction state of X chromosomes ([@R25]). Genome-wide chromosome conformation capture (Hi-C) studies showed the DCC remodels X chromosomes into a unique, sex-specific spatial conformation, distinct from that of autosomes by inducing TADs using its highest-affinity binding sites (*rex* sites) to mediate long-range chromatin interactions ([@R6]). We found that the H4K20me2 demethylase activity of DPY-21 contributes to both the compaction of X and the DCC-driven remodeling of X topology.

Chromosome volume measurements performed in gut nuclei of wild-type and mutant adults showed that the fraction of total chromosome volume occupied by X increased by 30% in all three *dpy-21(JmjC)* mutants (*P* \< 10^−6^, two-sided Wilcoxon rank-sum test) ([@R4]). In contrast, X volume was not significantly changed (*P* = 0.2) in a dosage compensation mutant (*sdc-1(null)*) that has normal H4K20me1 enrichment on X and comparably modest dosage compensation defects as in *dpy-21(JmjC)* mutants. Thus, the increase in X-chromosome volume is not a byproduct of changes in gene expression, and H4K20me1 contributes directly to X-chromosome compaction.

The effect of H4K20me1 enrichment on the remodeling of X-chromosome topology was determined by investigating the timing of TAD boundary formation relative to the timing of DPY-21 binding to X and by genome-wide conformation capture experiments (Hi-C) to determine the position and degree of TAD boundary formation in *dpy-21(JmjC)* mutants.

Fluorescence in situ hybridization (FISH) experiments revealed that the DCC-dependent TAD boundary at *rex-14* started to form by the 80--120-cell stage and was well formed by the 180--250-cell stage, before DPY-21 was reliably detected on X chromosomes by immunofluores-cence ([@R4]). Thus, H4K20me2 demethylase activity is not essential to initiate the formation of DCC-dependent TADs. However, Hi-C experiments comparing TADs in wild-type and *dpy-21(JmjC)* mutants revealed that DCC-dependent TAD boundaries were diminished in the mutant ([Fig. 6A--C](#F6){ref-type="fig"}). Insulation profiles showed that TAD boundaries were formed at the same 17 locations on X chromosomes of wild-type and mutant animals, but the difference in insulation profiles showed that the strength of all eight DCC-dependent TAD boundaries on X was significantly reduced in *JmjC* mutants ([Fig. 6G](#F6){ref-type="fig"}; [@R4]). In contrast, the nine DCC-independent TAD boundaries on X ([Fig. 6G](#F6){ref-type="fig"}) and the TAD boundaries on autosomes ([Fig. 6D--F,H](#F6){ref-type="fig"}) were not significantly weakened by the *dpy-21(JmjC)* mutation ([@R4]).

Analysis of Hi-C interaction frequencies (*Z*-scores) revealed an underlying cause for the defect in TAD boundary formation. In *dpy-21(JmjC)* mutants, interactions between sites within 1 Mb were increased significantly, whereas interactions between sites \>1 Mb apart were decreased significantly ([Fig. 6C](#F6){ref-type="fig"}; [@R4]). Among the reduced long-range interactions (\>1 Mb) were those between the DCC-dependent TAD boundaries and between the highest-affinity *rex* sites that mediate TAD boundary formation. Reduction in these interactions contributed to the loss in TAD boundary strength ([Fig. 6I](#F6){ref-type="fig"}). In contrast, interactions between DCC-independent boundaries on X were unchanged ([Fig. 6I](#F6){ref-type="fig"}), and interactions on autosomes showed moderate changes in the opposite direction ([Fig. 6F](#F6){ref-type="fig"}).

These results support a two-tiered model for TAD formation during dosage compensation. In the first stage, the condensin DCC initiates TAD formation prior to DPY-21 recruitment and hence via a demethylase-independent mechanism that promotes long-range interactions between the highest-affinity DCC-binding sites. In the second stage, DPY-21 binds to X and catalyzes enrichment of H4K20me1, thereby enhancing long-range DNA interactions across X. X-chromosome compaction is generally increased, and the increase in long-range interactions among *rex* sites strengthens TAD boundaries.

IN GERM CELLS, H4K20me2 DEMETHYLASE ENRICHES H4K20me1 ON AUTOSOMES BY A DCC-INDEPENDENT MECHANISM TO PROMOTE CHROMOSOME COMPACTION {#S5}
==================================================================================================================================

As in somatic cells, H4K20me1 shows a dynamic pattern of enrichment in germ cells. H4K20me1 levels are high on all mitotic chromosomes in the gonad and become reduced as nuclei enter meiosis ([Fig. 7A,B](#F7){ref-type="fig"}). By early pachytene, H4K20me1 is enriched only on autosomes of both sexes and absent from X chromosomes ([Fig. 7B](#F7){ref-type="fig"}), raising the question of whether DPY-21 also controls H4K20me1 levels in the germline, where the DCC does not assemble or function. In gonads of *dpy-21(JmjC)* mutants, H4K20me1 levels remained high on mitotic chromosomes, but H4K20me1 was absent from all pachytene chromosomes, indicating that the JmjC demethylase is essential in germ cells for autosomal enrichment of H4K20me1 during meiosis but not mitosis ([Fig. 7A,B](#F7){ref-type="fig"}). The localization of DPY-21 met all expectations for a demethylase that regulates autosomal levels of H4K20me1 during meiosis but not mitosis: DPY-21 bound to autosomes but not X chromosomes of pachytene nuclei and failed to bind mitotic chromosomes ([Fig. 7A,C](#F7){ref-type="fig"}).

These findings prompted the question of whether DPY-21 and H4K20me1 regulate chromosome compaction during germ cell development. A change in meiotic chromo some compaction should be reflected in a change in length of the chromosome axis. Indeed, measurements of axis lengths in 3D for chromosomes X and I in wild-type and *dpy-21(JmjC)* mutants revealed that X axis length was not different in the mutants, as predicted by the absence of H4K20me1 and DPY-21 ([Fig. 7D](#F7){ref-type="fig"}). However, chromosome I axis length was extended by 20% in mutants ([Fig. 7D](#F7){ref-type="fig"}), indicating that selective binding of DPY-21, and hence H4K20me1 enrichment, regulates higher-order chromosome structure in germ cells. Because the key DCC subunits that recruit DPY-21 to X chromosomes in XX somatic cells are not expressed in the germline, the DPY-21 demethylase activity must operate via a DCC-independent mechanism using factors that either recruit DPY-21 to autosomes or repel it from X. Thus, DPY-21 is an adaptable chromatin regulator that is harnessed during development for distinct biological functions through different binding partners ([Fig. 8](#F8){ref-type="fig"}). In both somatic cells and germ cells, H4K20me1 modulates 3D chromosome architecture, demonstrating the direct link between chromatin modification and higher-order chromosome structure.

CONCLUSION {#S6}
==========

We showed the function of chromatin modification in establishing higher-order chromosome structure during gene regulation. Moreover, discovery of ubiquitous H4K20me2 demethylases that act in worms and mammals to enhance H4K20me1 levels further expands our opportunity to dissect the dynamic regulation of H4K20 methylation essential for DNA replication, DNA damage response, chromosome segregation, gene regulation, and development. Prior studies suggested that H4K20 methylation was likely to be controlled by demethylases as well as previously characterized methyltransferases, but the H4K20me2/me3 demethylases responsible for such regulation had not been identified ([@R46]).

The finding that the DPY-21 and mROSBIN demeth-ylases lack obvious DNA and chromatin-binding domains to confer target specificity provides the flexibility for these enzymes to be recruited to different genomic locations by diverse mechanisms to control essential nuclear processes. In general, though, only a limited number of DNA-binding factors are known to target histone demethylases to chromatin ([@R11]), making the recruitment of an H4K20me2 demethylase to X chromosomes by a specialized condensin complex a highly tractable model. DCC binding and spreading distributes demethylase activity chromosome-wide. Thus, the DCC acts as an "eraser" of a prominent histone posttranslational modification, increasing H4K20me1 levels along X by activating an H4K20me2 demethylase rather than regulating an H4K20 methyltransferase.

DPY-21's role in chromatin modification further illustrates how dosage compensation evolved by co-opting conserved machinery used in other biological processes for the new task of fine-tuning X-chromosome expression. Our observations suggest that other condensin and structural maintenance of chromosomes (SMC) complexes could act as scaffolds to recruit proteins with chromosome-modifying activities.

The enrichment of H4K20me1 on the inactive X chromosome of female mice ([@R21]) makes our discoveries directly relevant for mammalian development. The long noncoding RNA *XIST*, the trigger of mammalian X inactivation, induces accumulation of H4K20me1 on X, but X inactivation per se is not required for H4K20me1 enrichment, suggesting that H4K20me1 might contribute to establishing inactivation. Consistent with this interpretation, knockout of the mouse H4K20me1 methyltransferase causes decondensation of X ([@R36]). Thus, our observations offer new directions for unraveling the regulation and function of H4K20me1 in X-chromosome inactivation and other mechanisms of gene control that act over long distances. Our findings also provide newavenues for understanding the mechanisms by which chromatin modifications help remodel higher-order chromosome structure during development.

We thank Deborah Stalford for drafting the figures. This work was supported by National Institutes of Health grant R01 GM030702 to B.J.M. and by the Howard Hughes Medical Institute.

![Overview of dosage compensation in *Caenorhabditis elegans*. (*A*) In XX hermaphrodites, a dosage compensation complex (DCC) binds to both X chromosomes to reduce gene expression by half, thereby equalizing expression with that from the single male X. The product of the XX-specific gene *sdc-2* triggers assembly of the DCC onto X. In XO males, *xol-1*, the male-specific regulator of sex determination and dosage compensation, represses *sdc-2*, thereby preventing the DCC from binding to the male X. (*B*) The DCC compared with condensin I of other eukaryotes. The DCC condensin subunits (MIX-1, DPY-27, DPY-26, DPY-28, and CAPG-1) are color matched to their condensin I homologs ([@R7]; [@R30]; [@R31]). All DCC condensin subunits except DPY-27 also function in other condensins that act in *C. elegans* mitosis and meiosis. The DPY-27 paralog SMC-4 (not shown) replaces DPY-27 in mitotic and meiotic condensins. The DCC likely arose by duplicating the gene encoding SMC-4 and modifying it to create DPY-27 for a specific role in gene expression ([@R13]). In addition to condensin subunits, the DCC also includes a novel XX-specific protein with a large coiled-coil domain (SDC-2) ([@R9]) that triggers assembly of the DCC onto X chromosomes. Two DCC subunits aid SDC-2 in recruiting the complex to X, SDC-3 (a zinc finger protein) and DPY-30 (a subunit of the MLL/COMPASS H3K4me3 methyltransferase complex) ([@R20]; [@R16]; [@R8]; [@R38]). Two subunits, SDC-1 (a zinc finger protein) and DPY-21, are required for DCC activity but not assembly ([@R33]; [@R51]). DPY-21 is a Jumonji C H4K20me2 demethylase described here and in ([@R4]). (*C*) DCC recruitment sites across X chromosomes. The DCC recruitment elements on X (*rex*) were discovered by the combination of genome-wide approaches (ChIP-chip and ChIP-seq) to identify DCC-binding sites without regard to autonomous recruitment ability and a functional approach in vivo to assess DCC binding to sites detached from X ([@R17]; [@R6]). *rex* sites are distributed across X and confer X-chromosome specificity to dosage compensation. DCC binding to *rex* sites facilitates DCC spreading across X to sites that cannot bind the complex if detached from X ([@R38]). Several of the strongest *rex* sites (red) are essential for formation of topologically associated domains (TADs). (*D*) Cartoon model of TAD formation on a segment of X. (*Top*) The DCC remodels the topology of X into a hermaphrodite-specific conformation by forming TADs. DCC-dependent looping interactions between high-affinity *rex* sites located at TAD boundaries direct TAD formation ([@R6]). (*Middle*) Deletion of the high-affinity site *rex-47* located at a DCC-dependent TAD boundary eliminates boundary formation ([@R6]). (*Bottom*) Severe disruption of DCC binding by an *sdc-2* mutation eliminates formation of all DCC-dependent TADs on X ([@R6]).](nihms959933f1){#F1}

![H4K20me1 enrichment on the repressed X chromosomes is a shared feature of diverse dosage compensation strategies. (*A*) Dosage-compensated X chromosomes of *C. elegans* hermaphrodites have dosage compensation complex (DCC)-dependent H4K20me1 enrichment. H4K20me1 enrichment on the inactive X chromosome of female mammals requires the long noncoding RNA XIST that triggers X inactivation. For neither strategy had the mechanism of H4K20me1 enrichment been determined. (*B*) H4K20 methylation controls myriad nuclear functions, but the mechanisms that regulate different H4K20 methylation states are not well understood. H4K20me2/me3 demethylases had not been identified.](nihms959933f2){#F2}

![1.8 Å structure of the DPY-21 JmjC demethylase domain. (*A*) DPY-21^1210--1617^ structure in complex with α-KG (black) and Fe^2+^ (orange) showing JmjC domain (yellow), JmjN (blue), β-hairpin (magenta), and mixed domain (green). (Adapted from [@R4].) (*B*) Active site of DPY-21^1210--1617^ showing JmjC domain residues (yellow) in complex with Fe^2+^ (orange), α-KG (black), and water molecules (red). Facial triad residues H1452 and D1454 (red letters) were changed to alanines for in vitro and in vivo studies. The electron density, 2*F*~o~--*F*~c~ (mesh), contoured at 1.0 σ above the mean is shown for Fe^2+^, α-KG, and water molecules. (Adapted from [@R4].) (*C*) Evolutionary conservation of DPY-21 JmjC domain (magenta) in ROSBIN proteins across species.](nihms959933f3){#F3}

![DPY-21 JmjC H4K20me2 demethylase enriches H4K20me1 on X in vivo. (*A*) Confocal images of an interphase nucleus from a 376-cell wild-type embryo (*top*) and an interphase nucleus from a 335-cell *dpy-21(JmjC)* mutant embryo (*bottom*) stained with DAPI and antibodies to DPY-21, dosage compensation complex (DCC) subunit SDC-3, and H4K20me1. The JmjC mutation does not affect binding of DPY-21 to X, but it does disrupt the H4K20me1 enrichment on X. (*B*) Metaphase nucleus from a 376-cell wild-type embryo (*top*) and metaphase nucleus from a 335-cell *dpy-21(JmjC)* mutant embryo (*bottom*) stained as in *A*. During mitosis, DPY-21 dissociates from X, but SDC-3 remains bound. The JmjC mutation does not affect the H4K20me1 level on mitotic chromosomes. (*C*) ChIP-seq profiles show spike-in-corrected H4K20me1 enrichment in representative regions of chromosome X and chromosome IV in wild-type, *dpy-21(JmjC)*, and *dpy-21(null)* mutant embryos. X enrichment of H4K20me1 is lost in *dpy-21* mutants, but H4K20me1 levels are unchanged on autosomes. (Based on data from [@R4].)](nihms959933f4){#F4}

![X-chromosome gene expression is elevated relative to autosomes in *dpy-21(JmjC)* mutants. Cumulative plots show the distribution of expression changes for genes on X and for each individual autosome in *dpy-21(JmjC)* mutant versus wild-type embryos as assayed by RNA-seq. The *x*-axis represents the log~2~ fold change in expression. X-chromosome gene expression is elevated compared to that of each autosome in *dpy-21(y607 JmjC)*, *dpy-21(y618 JmjC)*, *dpy-21(e428 null)* mutants (*P* \< 2.2 × 10^−16^, one-sided Wilcoxon rank-sum test). (Based on data from [@R4].)](nihms959933f5){#F5}

![DPY-21 demethylase activity modulates X-chromosome topology. (*A,B,D,E*) Heat maps of Hi-C data binned at 50-kb resolution show chromatin interaction frequencies on chromosomes X and I in wild-type and *dpy-21(JmjC)* mutant embryos. These heat maps show results from one of two replicates. Heat maps combining both replicates are presented in [@R4], with the same conclusions. (*C,F*) *Z*-score difference heat maps of Hi-C data in *A,B* and *D,E*, respectively, binned at 50-kb resolution show chromatin interactions that increase (orange-red) and decrease (blue) on X (C) and I (*F*) in *dpy-2(JmjC)* mutant versus wild-type embryos. (*G,H*) Insulation plots for chromosomes X or I of wild-type (gray) or *dpy-21(JmjC)* mutant (blue) embryos and insulation difference plots (red) from data in *A*--*E.* Black bars, location of topologically associated domain (TAD) boundaries in wild-type embryos. Red dots, dosage compensation complex (DCC)-dependent boundaries greatly diminished or eliminated upon DCC depletion ([@R6]). Each has a high-affinity *rex* site. An insulation score reflects the cumulative interactions occurring across each interval. Minima denote areas of high insulation classified as TAD boundaries. The difference between insulation profiles of wild-type and *dpy-21(JmjC)* mutants reflects the change in boundary strength. An increase in insulation score at a TAD boundary means less insulation in the mutant, indicating a weakening of the boundary. DCC-dependent TAD boundaries on X were reduced in *dpy-21(JmjC)* mutants, but DCC-independent boundaries on X and autosomes were not significantly changed. (*I*) Three-dimensional profiles of average Hi-C interaction frequencies (*Z*-scores) in 50-kb bins around pairs of top 25 *rex* sites, DCC-dependent boundaries on X, and DCC-independent boundaries on X in wild-type or *dpy-21(JmjC)* mutant embryos. Profiles are centered at 0. Interactions between *rex* sites and DCC-dependent boundaries are reduced in demethylase mutants. (Adapted from [@R4].)](nihms959933f6){#F6}

![DPY-21 JmjC demethyase acts in germ cells to enrich H4K20me1 and compact autosomes. (*A*) Confocal images of metaphase chromosomes from the mitotic zones of *dpy-21(5*′-*FLAG*) and *dpy-21(5*′-*FLAG, JmjC)* gonads costained with H4K20me1 and FLAG antibodies. H4K20me1 is highly enriched on all mitotic chromosomes, but DPY-21 does not localize to mitotic chromosomes. Inactivation of the DPY-21 demethylase does not reduce H4K20me1 levels on mitotic chromosomes. Scale bar, 1 μm. (*B*) Pachytene nuclei from *dpy-21(5*′*-FLAG)* and *dpy-21*(*5*′*-FLAG, JmjC)* XX gonads stained with antibodies against H4K20me1 and the X-chromosome-specific marker HIM-8. H4K20me1 is selectively enriched on autosomes in pachytene nuclei in the *dpy-21(5*′*-Flag)* strain but absent from X (*top*). H4K20me1 is absent from all chromosomes in pachytene nuclei of *dpy-21(JmjC)* mutant XX gonads (*bottom*). (*C*) Pachytene nuclei from *dpy-21(5*′*-Flag)* and *dpy-21*(*5*′*-Flag, JmjC)* XX gonads stained with antibodies against FLAG-tagged DPY-21 and HIM-8. DPY-21 specifically localizes to autosomes but not to X, consistent with its demethylation of only autosomes. Scale bars (*B, C*), 2 μm. (*D*) DPY-21 demethylase is required for full compaction of autosomes in germ cells. (*Left*) High-resolution image of a pachytene nucleus from a wild-type gonad stained with a FISH probe to chromosome I (blue) and antibodies to axis protein HTP-3 (green) and X-specific protein HIM-8 (red). The 3D traces of X and I (yellow) were used to straighten each chromosome. (*Middle*) Computationally straightened X and I from wild-type and *dpy-21(JmjC)* gonads are displayed horizontally. Chromosome tracing was performed on nuclei in the last quarter of pachytene. Average total axis length and standard error of the mean (SEM) are shown below each axis. (*Right*) Box plots show the ratios of I to X axis lengths in wild-type and *dpy-21(JmjC)* pachytene nuclei. The I to X ratios are significantly lower in wild-type versus *dpy-21(JmjC)* gonads (*P* = 1.7 × 10^−8^, two-sided Wilcoxon rank-sum test). (Adapted from [@R4].)](nihms959933f7){#F7}

![An H4K20me2 histone demethylase regulates 3D chromosome structure and gene expression by modulating the dynamic enrichment of H4K20me1. The 1.8 Å crystal structure and biochemical activity of DPY-21 revealed a new, highly conserved H4K20me2 JmjC demethylase subfamily that converts H4K20me2 to H4K20me1 in vitro. In somatic cells, DPY-21 binds to X chromosomes via the dosage compensation complex (DCC) and enriches H4K20me1 to repress gene expression. The H4K20me1 enrichment controls the higher-order structure of X chromosomes by facilitating compaction and topologically associated domain (TAD) formation. In germ cells, DPY-21 enriches HK20me1 on autosomes in a DCC-independent manner to promote chromosome compaction. (Adapted from [@R4].)](nihms959933f8){#F8}

[^1]: Present address: Shanghai Institute of Precision Medicine, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
